REYATAZ
BRISTOL-MYERS SQUIBB CANADA
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is REYATAZ discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that REYATAZ 300MG has been permanently discontinued (last updated July 6, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is REYATAZ not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
REYATAZ
BRISTOL-MYERS SQUIBB CANADA
TEVA-ATAZANAVIR
TEVA CANADA LIMITED
APO-ATAZANAVIR
APOTEX INC
JAMP ATAZANAVIR
JAMP PHARMA CORPORATION
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02294176
Strength
300MG
Dosage Form
CAPSULE
Route
ORAL
Compare with another product →
Shortage History
Other Products from BRISTOL-MYERS SQUIBB CANADA
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
100MG · DIN 02281066
0.5MG · DIN 02282224
120000000CELLS · DIN 02527138
15MG · DIN 02532573
5MG · DIN 02532557
2.5MG · DIN 02532549
10MG · DIN 02532565
100MG · DIN 00360414
125MG · DIN 02163675
250MG · DIN 02163683
250MG · DIN 02163659
500MG · DIN 02163667